During the 8th annual Microbiome Movement Drug Development Europe, held in Barcelona (Spain), Microbiomepost conducted an exclusive interview with Aran Singanayagam, research group leader at Imperial College London (UK).
We delved into the critical functions of the respiratory microbiome in maintaining healthy bodily equilibrium and examined how disturbances in the airway microbiome are instrumental in the development of chronic lung diseases. Additionally, we explored the promising horizon of microbiome manipulation as an innovative approach to treat chronic pulmonary conditions.
